<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22736030</PMID><DateCompleted><Year>2013</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2083</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>19</Issue><PubDate><Year>2012</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>A polyglutamine expansion disease protein sequesters PTIP to attenuate DNA repair and increase genomic instability.</ArticleTitle><Pagination><StartPage>4225</StartPage><EndPage>4236</EndPage><MedlinePgn>4225-36</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/hmg/dds246</ELocationID><Abstract><AbstractText>Glutamine (Q) expansion diseases are a family of degenerative disorders caused by the lengthening of CAG triplet repeats present in the coding sequences of seemingly unrelated genes whose mutant proteins drive pathogenesis. Despite all the molecular evidence for the genetic basis of these diseases, how mutant poly-Q proteins promote cell death and drive pathogenesis remains controversial. In this report, we show a specific interaction between the mutant androgen receptor (AR), a protein associated with spinal and bulbar muscular atrophy (SBMA), and the nuclear protein PTIP (Pax Transactivation-domain Interacting Protein), a protein with an unusually long Q-rich domain that functions in DNA repair. Upon exposure to ionizing radiation, PTIP localizes to nuclear foci that are sites of DNA damage and repair. However, the expression of poly-Q AR sequesters PTIP away from radiation-induced nuclear foci. This results in sensitivity to DNA-damaging agents and chromosomal instabilities. In a mouse model of SBMA, evidence for DNA damage is detected in muscle cell nuclei and muscular atrophy is accelerated when one copy of the gene encoding PTIP is removed. These data provide a new paradigm for understanding the mechanisms of cellular degeneration observed in poly-Q expansion diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Zhigang</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yipin</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Nan</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Merry</LastName><ForeName>Diane E</ForeName><Initials>DE</Initials></Author><Author ValidYN="Y"><LastName>Sekiguchi</LastName><ForeName>JoAnn M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Ferguson</LastName><ForeName>David O</ForeName><Initials>DO</Initials></Author><Author ValidYN="Y"><LastName>Lieberman</LastName><ForeName>Andrew P</ForeName><Initials>AP</Initials></Author><Author ValidYN="Y"><LastName>Dressler</LastName><ForeName>Gregory R</ForeName><Initials>GR</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DK073722</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS055746</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI063058</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK073722</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS055746</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DK054740</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C485876">PAXIP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical><Chemical><RegistryNumber>26700-71-0</RegistryNumber><NameOfSubstance UI="C097188">polyglutamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="Y">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042822" MajorTopicYN="Y">Genomic Instability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019680" MajorTopicYN="Y">Trinucleotide Repeat Expansion</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22736030</ArticleId><ArticleId IdType="pmc">PMC3441122</ArticleId><ArticleId IdType="doi">10.1093/hmg/dds246</ArticleId><ArticleId IdType="pii">dds246</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>La Spada A.R., Taylor J.P. Repeat expansion disease: progress and puzzles in disease pathogenesis. Nat. Rev. Genet. 2010;11:247&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4704680</ArticleId><ArticleId IdType="pubmed">20177426</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T., Katada S., Onodera O. Polyglutamine diseases: where does toxicity come from? what is toxicity? where are we going? J. Mol. Cell. Biol. 2010;2:180&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">20410236</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeyama K., Ito S., Yamamoto A., Tanimoto H., Furutani T., Kanuka H., Miura M., Tabata T., Kato S. Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron. 2002;35:855&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pubmed">12372281</ArticleId></ArticleIdList></Reference><Reference><Citation>Montie H.L., Cho M.S., Holder L., Liu Y., Tsvetkov A.S., Finkbeiner S., Merry D.E. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 2009;18:1937&#x2013;1950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2678926</ArticleId><ArticleId IdType="pubmed">19279159</ArticleId></ArticleIdList></Reference><Reference><Citation>Klement I.A., Skinner P.J., Kaytor M.D., Yi H., Hersch S.M., Clark H.B., Zoghbi H.Y., Orr H.T. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell. 1998;95:41&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">9778246</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh D.P., Figueroa K., Hoang N., Pulst S.M. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat. Genet. 2000;26:44&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">10973246</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowman A.B., Yoo S.Y., Dantuma N.P., Zoghbi H.Y. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Hum. Mol. Genet. 2005;14:679&#x2013;691.</Citation><ArticleIdList><ArticleId IdType="pubmed">15661755</ArticleId></ArticleIdList></Reference><Reference><Citation>Slow E.J., Graham R.K., Osmand A.P., Devon R.S., Lu G., Deng Y., Pearson J., Vaid K., Bissada N., Wetzel R., et al. Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc. Natl Acad. Sci. USA. 2005;102:11402&#x2013;11407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1183566</ArticleId><ArticleId IdType="pubmed">16076956</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrasate M., Mitra S., Schweitzer E.S., Segal M.R., Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 2004;431:805&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pubmed">15483602</ArticleId></ArticleIdList></Reference><Reference><Citation>Saudou F., Finkbeiner S., Devys D., Greenberg M.E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 1998;95:55&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">9778247</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunah A.W., Jeong H., Griffin A., Kim Y.M., Standaert D.G., Hersch S.M., Mouradian M.M., Young A.B., Tanese N., Krainc D. Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science. 2002;296:2238&#x2013;2243.</Citation><ArticleIdList><ArticleId IdType="pubmed">11988536</ArticleId></ArticleIdList></Reference><Reference><Citation>McCampbell A., Taylor J.P., Taye A.A., Robitschek J., Li M., Walcott J., Merry D., Chai Y., Paulson H., Sobue G., et al. CREB-binding protein sequestration by expanded polyglutamine. Hum. Mol. Genet. 2000;9:2197&#x2013;2202.</Citation><ArticleIdList><ArticleId IdType="pubmed">10958659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucifora F.C., Jr, Sasaki M., Peters M.F., Huang H., Cooper J.K., Yamada M., Takahashi H., Tsuji S., Troncoso J., Dawson V.L., et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science. 2001;291:2423&#x2013;2428.</Citation><ArticleIdList><ArticleId IdType="pubmed">11264541</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffan J.S., Kazantsev A., Spasic-Boskovic O., Greenwald M., Zhu Y.Z., Gohler H., Wanker E.E., Bates G.P., Housman D.E., Thompson L.M. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc. Natl Acad. Sci. USA. 2000;97:6763&#x2013;6768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC18731</ArticleId><ArticleId IdType="pubmed">10823891</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuda H., Jafar-Nejad H., Patel A.J., Sun Y., Chen H.K., Rose M.F., Venken K.J., Botas J., Orr H.T., Bellen H.J., et al. The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins. Cell. 2005;122:633&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pubmed">16122429</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L., Jeong H., Borovecki F., Parkhurst C.N., Tanese N., Krainc D. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell. 2006;127:59&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">17018277</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai W., Jeong H., Cui L., Krainc D., Tjian R. In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets. Cell. 2005;123:1241&#x2013;1253.</Citation><ArticleIdList><ArticleId IdType="pubmed">16377565</ArticleId></ArticleIdList></Reference><Reference><Citation>Helmlinger D., Tora L., Devys D. Transcriptional alterations and chromatin remodeling in polyglutamine diseases. Trends Genet. 2006;22:562&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">16911843</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan C.L., Lieberman A.P. Spinal and bulbar muscular atrophy: a motoneuron or muscle disease? Curr. Opin. Pharmacol. 2008;8:752&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2603477</ArticleId><ArticleId IdType="pubmed">18775514</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M., Adachi H., Waza M., Banno H., Suzuki K., Tanaka F., Doyu M., Sobue G. Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA) Exp. Neurol. 2006;200:8&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">16513111</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperfeld A.D., Karitzky J., Brummer D., Schreiber H., Haussler J., Ludolph A.C., Hanemann C.O. X-linked bulbospinal neuronopathy: Kennedy disease. Arch. Neurol. 2002;59:1921&#x2013;1926.</Citation><ArticleIdList><ArticleId IdType="pubmed">12470181</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy W.R., Alter M., Sung J.H. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 1968;18:671&#x2013;680.</Citation><ArticleIdList><ArticleId IdType="pubmed">4233749</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobue G., Hashizume Y., Mukai E., Hirayama M., Mitsuma T., Takahashi A. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain. 1989;112(Pt 1):209&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">2917278</ArticleId></ArticleIdList></Reference><Reference><Citation>Enokido Y., Tamura T., Ito H., Arumughan A., Komuro A., Shiwaku H., Sone M., Foulle R., Sawada H., Ishiguro H., et al. Mutant huntingtin impairs Ku70-mediated DNA repair. J. Cell Biol. 2010;189:425&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2867301</ArticleId><ArticleId IdType="pubmed">20439996</ArticleId></ArticleIdList></Reference><Reference><Citation>Illuzzi J., Yerkes S., Parekh-Olmedo H., Kmiec E.B. DNA breakage and induction of DNA damage response proteins precede the appearance of visible mutant huntingtin aggregates. J. Neurosci. Res. 2009;87:733&#x2013;747.</Citation><ArticleIdList><ArticleId IdType="pubmed">18831068</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho Y.W., Hong T., Hong S., Guo H., Yu H., Kim D., Guszczynski T., Dressler G.R., Copeland T.D., Kalkum M., et al. PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J. Biol. Chem. 2007;282:20395&#x2013;20406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2729684</ArticleId><ArticleId IdType="pubmed">17500065</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel S.R., Kim D., Levitan I., Dressler G.R. The BRCT-domain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex. Dev. Cell. 2007;13:580&#x2013;592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2100379</ArticleId><ArticleId IdType="pubmed">17925232</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Z., Cho Y.W., Kim J.E., Ge K., Chen J. Accumulation of Pax2 transactivation domain interaction protein (PTIP) at sites of DNA breaks via RNF8-dependent pathway is required for cell survival after DNA damage. J. Biol. Chem. 2009;284:7284&#x2013;7293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2652327</ArticleId><ArticleId IdType="pubmed">19124460</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Prindle M.J., Dressler G.R., Yu X. PTIP regulates 53BP1 and SMC1 at the DNA damage sites. J. Biol. Chem. 2009;284:18078&#x2013;18084.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2709350</ArticleId><ArticleId IdType="pubmed">19414588</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniel J.A., Santos M.A., Wang Z., Zang C., Schwab K.R., Jankovic M., Filsuf D., Chen H.T., Gazumyan A., Yamane A., et al. PTIP promotes chromatin changes critical for immunoglobulin class switch recombination. Science. 2010;329:917&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3008398</ArticleId><ArticleId IdType="pubmed">20671152</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwab K.R., Patel S.R., Dressler G.R. Role of PTIP in class switch recombination and long-range chromatin interactions at the immunoglobulin heavy chain locus. Mol. Cell. Biol. 2011;31:1503&#x2013;1511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3135287</ArticleId><ArticleId IdType="pubmed">21282469</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho E.A., Prindle M.J., Dressler G.R. BRCT domain-containing protein PTIP is essential for progression through mitosis. Mol. Cell. Biol. 2003;23:1666&#x2013;1673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC151700</ArticleId><ArticleId IdType="pubmed">12588986</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M., Ren H., Liu J., Cadigan K.M., Patel S.R., Dressler G.R. Drosophila ptip is essential for anterior/posterior patterning in development and interacts with the PcG and trxG pathways. Development. 2009;136:1929&#x2013;1938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2680114</ArticleId><ArticleId IdType="pubmed">19429789</ArticleId></ArticleIdList></Reference><Reference><Citation>Manke I.A., Lowery D.M., Nguyen A., Yaffe M.B. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science. 2003;302:636&#x2013;639.</Citation><ArticleIdList><ArticleId IdType="pubmed">14576432</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X., Chini C.C., He M., Mer G., Chen J. The BRCT domain is a phospho-protein binding domain. Science. 2003;302:639&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pubmed">14576433</ArticleId></ArticleIdList></Reference><Reference><Citation>Walcott J.L., Merry D.E. Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy. J. Biol. Chem. 2002;277:50855&#x2013;50859.</Citation><ArticleIdList><ArticleId IdType="pubmed">12388541</ArticleId></ArticleIdList></Reference><Reference><Citation>Grierson A.J., Mootoosamy R.C., Miller C.C. Polyglutamine repeat length influences human androgen receptor/c-Jun mediated transcription. Neurosci. Lett. 1999;277:9&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">10643885</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman A.P., Harmison G., Strand A.D., Olson J.M., Fischbeck K.H. Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor. Hum. Mol. Genet. 2002;11:1967&#x2013;1976.</Citation><ArticleIdList><ArticleId IdType="pubmed">12165558</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp M.Q., Poort J.L., Baqri R.M., Lieberman A.P., Breedlove S.M., Miller K.E., Jordan C.L. Impaired motoneuronal retrograde transport in two models of SBMA implicates two sites of androgen action. Hum. Mol. Genet. 2011;20:4475&#x2013;4490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196895</ArticleId><ArticleId IdType="pubmed">21873607</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z., Dadgar N., Albertelli M., Gruis K., Jordan C., Robins D.M., Lieberman A.P. Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J. Clin. Invest. 2006;116:2663&#x2013;2672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1564432</ArticleId><ArticleId IdType="pubmed">16981011</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim J., Crespo-Barreto J., Jafar-Nejad P., Bowman A.B., Richman R., Hill D.E., Orr H.T., Zoghbi H.Y. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature. 2008;452:713&#x2013;718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2377396</ArticleId><ArticleId IdType="pubmed">18337722</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelsky N.B., Pennuto M., Smith R.B., Palazzolo I., Moore J., Nie Z., Neale G., Taylor J.P. Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron. 2010;67:936&#x2013;952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3514079</ArticleId><ArticleId IdType="pubmed">20869592</ArticleId></ArticleIdList></Reference><Reference><Citation>McManus S., Ebert A., Salvagiotto G., Medvedovic J., Sun Q., Tamir I., Jaritz M., Tagoh H., Busslinger M. The transcription factor Pax5 regulates its target genes by recruiting chromatin-modifying proteins in committed B cells. EMBO J. 2011;30:2388&#x2013;2404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3116275</ArticleId><ArticleId IdType="pubmed">21552207</ArticleId></ArticleIdList></Reference><Reference><Citation>Adelman C.A., De S., Petrini J.H. Rad50 is dispensable for the maintenance and viability of postmitotic tissues. Mol. Cell. Biol. 2009;29:483&#x2013;492.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2612516</ArticleId><ArticleId IdType="pubmed">19001091</ArticleId></ArticleIdList></Reference><Reference><Citation>Demuth I., Frappart P.O., Hildebrand G., Melchers A., Lobitz S., Stockl L., Varon R., Herceg Z., Sperling K., Wang Z.Q., et al. An inducible null mutant murine model of Nijmegen breakage syndrome proves the essential function of NBS1 in chromosomal stability and cell viability. Hum. Mol. Genet. 2004;13:2385&#x2013;2397.</Citation><ArticleIdList><ArticleId IdType="pubmed">15333589</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z., Dadgar N., Albertelli M., Scheller A., Albin R.L., Robins D.M., Lieberman A.P. Abnormalities of germ cell maturation and sertoli cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant protein. Am. J. Pathol. 2006;168:195&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1592669</ArticleId><ArticleId IdType="pubmed">16400023</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Capetillo O., Mahadevaiah S.K., Celeste A., Romanienko P.J., Camerini-Otero R.D., Bonner W.M., Manova K., Burgoyne P., Nussenzweig A. H2AX is required for chromatin remodeling and inactivation of sex chromosomes in male mouse meiosis. Dev. Cell. 2003;4:497&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pubmed">12689589</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Aprelikova O., Moens P., Deng C.X., Furth P.A. Impaired meiotic DNA-damage repair and lack of crossing-over during spermatogenesis in BRCA1 full-length isoform deficient mice. Development. 2003;130:2001&#x2013;2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">12642502</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard G.F., Goellner G.M., McMurray C.T., Haber J.E. Recombination-induced CAG trinucleotide repeat expansions in yeast involve the MRE11-RAD50-XRS2 complex. EMBO J. 2000;19:2381&#x2013;2390.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC384364</ArticleId><ArticleId IdType="pubmed">10811629</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundararajan R., Freudenreich C.H. Expanded CAG/CTG repeat DNA induces a checkpoint response that impacts cell proliferation in Saccharomyces cerevisiae. PLoS Genet. 2011;7:e1001339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3060079</ArticleId><ArticleId IdType="pubmed">21437275</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie M.E., Diyagama D., Neilson J., van Laar R., Dobrovic A., Holloway A., Smyth G.K. Empirical array quality weights in the analysis of microarray data. BMC Bioinformatics. 2006;7:261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1564422</ArticleId><ArticleId IdType="pubmed">16712727</ArticleId></ArticleIdList></Reference><Reference><Citation>Irizarry R.A., Wu Z., Jaffee H.A. Comparison of Affymetrix GeneChip expression measures. Bioinformatics. 2006;22:789&#x2013;794.</Citation><ArticleIdList><ArticleId IdType="pubmed">16410320</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>